<DOC>
	<DOCNO>NCT03084965</DOCNO>
	<brief_summary>Retrospective Study Patients With Type 2 Diabetes Mellitus Dapagliflozin Therapy Taiwan</brief_summary>
	<brief_title>Retrospective Study Patients With Type 2 Diabetes Mellitus Dapagliflozin Therapy Taiwan</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Outpatient equal 20 year age . 2 . T2DM patient initiate dapagliflozin May 1st 2016 second line third line oral antidiabetic therapy , either addon switch one another . Or initiate dapagliflozin adjunctive therapy T2DM subject treat insulin . 3 . Completed followup least 6 month regardless continuation dapagliflozin therapy . 4 . Will provide complete signed write informed consent . 1 . Subjects history SGLT2 inhibitor therapy dapagliflozin prior Baseline . 2 . Subjects Type 1 diabetes . 3 . Treatment investigational drug concurrently retrospective data collection period .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>